FDA Examines How Social Media Could Make Medications Safer


The Food and Drug Administration (FDA) is now investigating possible uses for social media in assessing product safety.

Henry Francis, FDA’s ‎deputy director of the Center for Drug Evaluation and Research, believes that social media posts - for example, complaints over a drug’s side effects - could be useful for tracking “big, bad and sudden” health-related phenomena. When combined with geolocation data, this information could help governments respond to disease outbreaks or instances of tainted drugs.

Read more about the initiative in Nextgov, and follow MEDITECH on Twitter for the latest information about the healthcare IT industry.